☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Sanofi
Sanofi to Highlight New Data from the P-II Study of Frexalimab for the Treatment of Multiple Sclerosis at AAN 2024
April 17, 2024
Sanofi Features P-IIb (STREAM-AD) Study Data of Amlitelimab for the Treatment of Atopic Dermatitis at AAD’24
March 11, 2024
Sanofi Highlights Results from the P-II Trial of Rilzabrutinib for the Treatement of Chronic Spontaneous Urticaria (CSU) at AAAAI...
February 26, 2024
Sanofi and Regeneron Report the US FDA’s Acceptance of sBLA for Dupixent with Priority Review to Treat COPD with Type 2 Inflammati...
February 23, 2024
Sanofi Highlights the Results for Nexviazyme (avalglucosidase alfa) in Clinical Evaluation for the Treatment of Pompe Disease
February 6, 2024
PharmaShots Weekly Snapshots (January 22 – January 25, 2024)
January 25, 2024
Load more...
Back to Home